Alex Delaney-Gesing

Caesar Luo, MD, shares the take-away points from his ASRS presentation, and how the topics from his talk may be applied day to day in retinal practice.

Theresa Heah, MD, provides an update on AsclepiX’s AXT107, which is derived from a cryptic peptide within collagen IV that works by activating naturally existing, homeostatic mechanisms of angiogenesis.

ASRS 2020: Josh Anderson speaks on the highlights from Alcon, including new data on the performance benefits of the Hypervit dual blade 20,000 cpm probe and the launch of the NGENUITY 1.4 upgrade.

Derek Kunimoto, MD, JD, focuses on Aviceda's technology, which will aim to target various immune system responses that contribute to pathology associated with dry AMD.

Dilraj Grewal, MD, associate professor of ophthalmology at Duke Eye Center/ director of grading at the Duke Reading Center, speaks on his presentation "Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis Following an Injectable Fluocinolone Acetonide Insert," during the virtual 2020 ASRS meeting.

ICYMI: Nir Israeli, co-founder and CEO of Sanoculis discusses the company's new alternative surgical procedure for glaucoma designed to create a single-patient-use sterile tool and a multi-use external machine.

ICYMI: Chris Adams, CEO of Diopter Corp, discusses the company's drug delivery contact lens technology in the pipeline that works to treat ocular surface disease, during the 2020 Glaucoma 360 meeting in San Francisco, California.

ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting.

ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).

ICYMI: Yvonne Ou, MD, discusses her presentation on "Apps for the visually challenged," during the 2020 Glaucoma 360 annual meeting in San Francisco, California.

Dale Heuer, MD discusses the importance of ophthalmologists identifying and providing more aggressive treatment care for patients with low/high risks of developing glaucoma.

ICYMI: Thomas Samuelson, MD,shares the key highlights from his presentation "Stents, trabs, and tubes: Decision-making in surgical glaucoma."

ICYMI: Robert Stamper, MD, offers an update on optical coherence tomography angiography in glaucoma during the 2020 Glaucoma 360 annual meeting.

Dee Stephenson, MD, ABO, discusses the highlights of her presentation "Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment ORA" during the 2020 ASCRS virtual meeting.